Covered recipient · General Payments record
MEGAN E MORGENTHALER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2023–2024
$1,250.77
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,191.69 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Axsome Therapeutics, Inc. | $246.80 | 3 |
| ABBVIE INC. | $196.08 | 7 |
| Amgen Inc. | $132.12 | 1 |
| Kyowa Kirin, Inc. | $121.81 | 1 |
| GENZYME CORPORATION | $117.14 | 1 |
| Abbott Laboratories | $110.60 | 1 |
| Exeltis, USA Inc. | $101.69 | 1 |
| Acerta Pharma LLC | $95.25 | 1 |
| Teva Pharmaceuticals USA, Inc. | $70.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $110.60 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341807 | CMS |
| ABBVIE INC. | $24.74 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693636 | CMS |
| ABBVIE INC. | $8.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693638 | CMS |
| ABBVIE INC. | $9.62 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693640 | CMS |
| ABBVIE INC. | $9.41 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693642 | CMS |
| ABBVIE INC. | $9.14 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693644 | CMS |
| ABBVIE INC. | $9.63 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693646 | CMS |
| ABBVIE INC. | $124.88 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693648 | CMS |
| Amgen Inc. | $132.12 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117332826 | CMS |
| AstraZeneca Pharmaceuticals LP | $95.25 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104279681 | CMS |
| Axsome Therapeutics, Inc. | $112.17 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148391608 | CMS |
| Axsome Therapeutics, Inc. | $12.82 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148391610 | CMS |
| Axsome Therapeutics, Inc. | $121.81 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148391606 | CMS |
| Exeltis, USA Inc. | $101.69 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150016787 | CMS |
| GENZYME CORPORATION | $117.14 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990117 | CMS |
| Kyowa Kirin, Inc. | $121.81 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127053671 | CMS |
| Teva Pharmaceuticals USA, Inc. | $70.20 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151607877 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.